Phase 2 Malignant Solid Tumor Clinical Trials
18 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–18 of 18 trials
Recruiting
Phase 1Phase 2
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc.428 enrolled7 locationsNCT07287995
Recruiting
Phase 2
A Study Evaluating the Activity of Anti-cancer Treatments Targeting Tumor Molecular Alterations/Characteristics in Advanced / Metastatic Tumors.
Malignant Solid Tumor
Centre Leon Berard455 enrolled10 locationsNCT04116541
Recruiting
Phase 1Phase 2
A Study of TAK-505 in Adults With Solid Tumors
Malignant Solid Tumors
Takeda151 enrolled15 locationsNCT07436728
Recruiting
Phase 1Phase 2
A Study of MHB042C in Patients With Advanced Solid Tumors
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd200 enrolled1 locationNCT07192107
Recruiting
Phase 1Phase 2
A Study of MHB009C in Patients With Advanced Solid Tumors
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd200 enrolled1 locationNCT07326488
Recruiting
Phase 1Phase 2
A Study of MHB048C in Patients With Advanced Solid Tumors
Advanced Malignant Solid TumormCRPC (Metastatic Castration-resistant Prostate Cancer)
Minghui Pharmaceutical (Hangzhou) Ltd200 enrolled1 locationNCT07192120
Recruiting
Phase 1Phase 2
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
Hepatocellular CarcinomaRefractory Solid TumorPediatric Solid Tumor+3 more
St. Jude Children's Research Hospital64 enrolled2 locationsNCT05468359
Recruiting
Phase 2
A Trial of SHR-4849 Combined With Other Antitumor Drugs in Patients With Malignant Solid Tumors
Malignant Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.120 enrolled1 locationNCT07028281
Recruiting
Phase 2
Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia
Malignant Solid Tumors
M.D. Anderson Cancer Center40 enrolled1 locationNCT06629584
Recruiting
Phase 1Phase 2
An Early Phase Trial of RPTR-1-201 in Advanced Solid Tumors
Advanced Malignant Solid Tumor
Repertoire Immune Medicines150 enrolled1 locationNCT07293754
Recruiting
Phase 1Phase 2
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant Tumors
Advanced Solid TumorMalignant Solid Tumor
Daiichi Sankyo250 enrolled25 locationsNCT04145622
Recruiting
Phase 2
A Trial of SHR-7787 Injection Combined With Other Anti-tumor Drugs in Patients With Malignant Solid Tumors
Malignant Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.400 enrolled2 locationsNCT07268040
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Study of SHR-1681 for Injection in Patients With Advanced Solid Tumors
Malignant Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.300 enrolled1 locationNCT06737731
Recruiting
Phase 1Phase 2
Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors
Malignant Solid Tumor
Jiangsu HengRui Medicine Co., Ltd.200 enrolled1 locationNCT06735144
Recruiting
Phase 1Phase 2
A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
Advanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd116 enrolled1 locationNCT07126665
Recruiting
Phase 2
A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors
Advanced Breast CancerAdvanced Malignant Solid Tumor
Minghui Pharmaceutical (Hangzhou) Ltd210 enrolled1 locationNCT07130383
Recruiting
Phase 1Phase 2
Phase I/II Study of SCTB39-1 in Advanced Solid Tumours
Advanced Malignant Solid Tumor
Sinocelltech Ltd.110 enrolled1 locationNCT07050641
Recruiting
Phase 1Phase 2
Plasmodium Immunotherapy for Advanced Malignant Solid Tumors
Advanced Malignant Solid Tumor
CAS Lamvac Biotech Co., Ltd.60 enrolled1 locationNCT04165590